FDA Clearance Tracker · P150004-S053
Dorsal Root Ganglion (DRG) System
Last checked: Nov 20, 2026Latest source record: Dec 30, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 30, 2021
Approved
Time to decision
94 days
Received Sep 27, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150004-S053
- Device name
- Dorsal Root Ganglion (DRG) System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- Sep 27, 2021
- Decided
- Dec 30, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150004
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval to add Midwest Sterilization Corporation located at 1204 Lenco Ave. Jackson, Mo 63755 as an alternate ethylene oxide (EO) sterility facility.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.